Anagrelide Impurity B |
|
| Synonyms: 2-Amino-5,6-dichloro-3(4H)-quinazoline Acetic Acid;(2-Amino-5,6-dichloroquinazolin-3(4H )-yl)acetic acid;USP Anagrelide Related Impurity B; Anagrelide Related Compound B | |
| Cat. No.: A50006 | CAS No.: 1159977-03-3 |
| MDL.: | Formula: C10H9Cl2N3O2 |
| F.W.274.10 | Purity: 99% |
| Storage: Refrigerator | |
|   | |
| Catalog Number: | A50006 | CAS No.: | 1159977-03-3 | |
| MDL: | Formula: | C10H9Cl2N3O2 | ||
| F.W.: | 274.10 | Purity: | 99% | |
| Package: | Unit: | |||
| Appearance: | M.P.: | |||
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | Stability: | |||
| Storage: | Refrigerator | Category: | Reference Standard | |
| Reference: | Molamas, M.S., et al.: J. Med. Chem., 34, 1492 (1991), Brogden, R.N., et al.: Drugs, 47, 809 (1994), Brase, S., et al.: Bioorg. Med. Chem. Lett., 10, 2415 (2002), | |||
| Application: | Anagrelide impurity B. Quinazolines derivatives are attractive targets because they form an important component of pharmacologically active compounds and are associated with a wide spectrum of biological activities ranging from anticonvulsant and antibacterial to antidiabetic. | |||
| Category: | Amines, Impurities, Nucleotides, Bases & Related Reagents, Pharmaceuticals, Intermediates & Fine Chemicals | |||








